Oligo-array CGH and gene expression profiling of NK cell neoplasms were employed in an effort to delineate the molecular pathogenesis involved. Oligo-array CGH identified two 6q21 regions that were most frequently deleted (36%; 14/39). One of these regions included POPDC3, PREP, PRDM1, ATG5 and AIM1, while the other included LACE1 and FOXO3. All genes located in these regions, except for POPDC3 and AIM1, were down-regulated in neoplastic samples, as determined by gene expression analysis, and were therefore considered as candidate tumor suppressor genes. A20 and HACE1, the well known tumor-suppressor genes located on 6q21-23, were included as candidate genes since they also demonstrated frequent genomic deletions and down-regulated expression. The Tet-OFF NK cell line NKL was subsequently established for functional analyses. Seven candidate genes were transduced into Tet-OFF NKL and forced re-expression was induced. Re-expression of FOXO3 and PRDM1 suppressed NKL proliferation, unlike the case following re-expression of the other genes. This effect was confirmed using another NK cell line, SNK10. Furthermore, genomic analyses detected nonsense mutations of PRDM1, leading to functional inactivation, in one cell line and one clinical sample. PRDM1 and FOXO3 are considered to play an important role in the pathogenesis of NK cell neoplasms.
Introduction
NK cell neoplasms are lymphoid malignancies with an aggressive clinical course. NK cell neoplasms are more prevalent in Asians and native Americans than in people from Western countries 1 . The WHO classification defines NK cell neoplasms as two major disease entities, aggressive NK cell leukemia (ANKL) and extranodal NK/T cell lymphoma, nasal type (ENKTL) 1, 2 . Neoplastic cells of both diseases express the NK cell markers CD16 and CD56, cytotoxic molecules, granzyme B and T cell-restricted intracellular antigen (TiA1), and EB-virus associated molecules EBV-LMP1 and EBER 1, 2 . The molecular pathogenesis of NK cell neoplasms remains unknown. This is due not only to the rare frequency of NK cell neoplasms, but also to the pathological features of numerous inflammatory cell infiltrates and necrotic changes. Most reports which have described chromosomal aberrations in NK cell neoplasms included less than 10 cases, and recurrent chromosomal translocations, which are often recognized in B cell neoplasms, have not been found in NK cell neoplasms [3] [4] [5] [6] . However, some gene expression profiling and array CGH analyses of NK cell neoplasms have been reported given the recent progress of molecular biotechnology [7] [8] [9] . We analyzed genomic aberrations of seventeen ANKL cases and ten ENKTL cases using array CGH, and described 2q gain and deletions of 6q16-27 and 7p15-22 as frequent abnormalities For personal use only. on April 13, 2017. by guest www.bloodjournal.org From lymphoma. They described HACE1, a well known tumor suppressor gene located in 6q, as a candidate tumor suppressor gene in ENKTL, although a functional analysis was not shown. They also reported that PDGFRA was up-regulated in ENKTL, and that its inhibitor imatinib suppressed NK cell line proliferation.
It has recently been accepted that in addition to genomic aberrations and changes in expression level, functional effects are also important in the exploration of cancer-associated genes [10] [11] [12] . Very few reports 13 have investigated the functional effects associated with the molecular pathogenesis of NK cell neoplasms by gene transduction. Hence, identification of the most likely tumor suppressor genes among the numerous candidate genes described in previous reports remains to be resolved [7] [8] [9] .
In this study, we identified FOXO3 and PRDM1 as important tumor suppressor genes of NK cell neoplasms as determined by a combination of array-CGH, gene expression profiling and functional analyses. Furthermore, nucleotide substitutions highly suspected as somatic mutations were detected in some clinical samples.
Methods

Samples and Cell lines
We collected 35 cases of NK cell neoplasms (nine ANKL and 26 ENKTL). The diagnoses were based on the WHO classification, 4 th edition. These samples were obtained from patients at Samsung Medical Center, Aichi Cancer Center, Fukuoka University and collaborating institutions. The analysis was performed at Aichi Cancer Center with the approval of the Institutional Review Board. Patient characteristics are described in Table 1 . Twenty-four cases, nos. 1 to 24, were cases analyzed in a previous report 9 . Eleven cases, nos. 25 to 35, were newly collected cases in this study. DNA and RNA samples were extracted according to previously described methods 9,14 .
We examined rearrangement of the TCR gene (γ chain) in case nos. 26, 28, 29, 30, 31, 32 Table 1 ). Normal NK cells from three healthy volunteers were isolated and analyzed as control samples. The detailed method employed for the isolation is described in Supplementary Methods.
Array CGH microarray and Gene expression profiling
We performed array CGH analysis using the Human Genome CGH 44A microarray (4426B) (Agilent Technologies, Santa Clara, CA, USA) comprising approximately 43,000 60-mer oligonucleotide probes. Normal human male genomic DNA from peripheral blood mononuclear cells was employed in all experiments as a reference sample 23 . Sample labeling and microarray processing were performed according to the manufacturer's protocol (www.agilent.com). Scanning
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From analysis was performed using the Agilent Micro Array Scanner (Agilent Technologies) and acquired array images were processed using Feature extractions version 9.1 (Agilent Technologies). The analytical software DNA analytics (Agilent Technologies) was then used for array CGH analysis. The ADM-1 algorithm (threshold 6.0) was adopted to detect genomic aberrations 24 . The probes on chromosomes X and Y were excluded from the analysis since each experiment was not sex-matched.
For the analysis of gene expression profiling, total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. The quality of the extracted RNA was ascertained using the Agilent Bioanalyzer (Agilent Technologies). The Low RNA Input Linear Amplification and Gene Expression Hybridization kits (Agilent Technologies) were used for RNA labeling and amplification. The Whole Human Genome 4X44k Oligomicroarray Kit which contains 43,377 60-mer probes and Gene Expression Hybridization kit (Agilent Technologies) were used for the hybridization of labeled RNA. The experimental protocol employed paralleled the manufacturer's protocol (www.agilent.com). Each oligo microarray slide was scanned and converted into a dataset for array CGH analysis. Statistical analysis of gene expression profiles including Gene set enrichment analysis (GSEA) 25 and Gene ontology analysis were performed using normalized data. A detailed description of these analyses can be found in the Supplementary Methods.
FISH
Dual-color fluorescence in situ hybridization (FISH) was performed to confirm the deletion of 6q21 (FOXO3) detected by array CGH analysis according to a previously described method
26
. For hybridization, a spectrum green-labeled probe at the centrometric region of chromosome 6 (CEP6) (Abbott Laboratories, Abbott park, IL) and a spectrum red-labeled RP11-118H13 probe were used for detection of the FOXO3 gene at chromosome band 6q21.
Semi-quantitative RT-PCR
cDNA was synthesized from one microgram total RNA using SuperScript II Reverse Transcriptase (Life Technologies, Milan, Italy). Semi-quantitative determination of FOXO3 and PRDM1 gene expression was assessed and compared with beta-actin gene as an internal control. The forward and reverse primers used for RT-PCR were as follows: beta-actin; forward (5`-gactacctcatgaagatc-3`) and reverse (5`-gatccacatctgctggaa-3`), FOXO3; forward (5`-ggtgcgttgcgtgccctact-3`) and reverse (5`-ccgtggcagttccaccgtgc-3`), PRDM1; forward (5`-caaatgtcagacttgcaacaagggc-3`) and reverse (5`-ggccagaatttccttctccactaca-3`). The PCR conditions were: 95°C for 3min and then 25 cycles (beta-actin) or 35 cycles (FOXO3 and PRDM1) at 95°C for 45 sec, 55°C (FOXO3 and beta-actin) or 53°C (PRDM1) for 45 sec, 72°C for 90 sec, and a final extension at 72°C for 10 min. The expected fragment sizes were: 464bp (beta-actin), 543bp (FOXO3) and 474bp (PRDM1). The intensity of each band in the agarose gel image was calculated using Image J software (http://rsbweb.nih.gov/ij/). The Student's t-test was used to determine significant differences. 
Mutation analysis of PRDM1 and FOXO3
The seven coding exons of PRDM1 and two coding exons of FOXO3 were amplified from genomic DNA by PCR. PCR primers were synthesized based on previous reports 27, 28 . Thirty-two clinical samples and seven cell lines were analyzed. Since there was no remaining genomic DNA, case nos. 25, 33 and 34 were not analyzed. Direct sequencing of PCR products was performed through capillary electrophoresis using the ABI3100 sequencer (Applied Biosystems).
Gene transduction to NK cell line
The pRetroX-Tet-Off Advanced retroviral vector and pRetroX-tight-Pur-multiple cloning site, included in the Retro-X Tet-Off Advanced Inducible Expression System (Clontech, Mountain View, CA), were used in this study. A detailed description concerning plasmid construction can be found in the Supplementary Methods.
Stable Tet-Off cell lines were generated following the manufacture`s protocol. NKL and SNK10 were chosen since these possess genomic loss of 6q. Doxycyclin was washed from Tet-Off NKL and 1x10 5 cells were re-suspended in 1ml medium. The medium was changed and diluted 10-fold (NKL) or 5-fold (SNK10) at Day 2. Cell numbers were determined using the trypan blue exclusion assay at Day 2, 4 and 6. The Student's t-test was used to determine significant differences.
Western blotting
Western blot analysis was performed essentially as previously described
29
. The transferred polyvinylidene fluoride membranes were incubated overnight with anti-FLAG M2 monoclonal antibody (Sigma, St Louis, MO), anti-actin antibody (AC-40 ; Sigma-Aldrich) or anti-A20 antibody (59A426; Abcam, Cambridge, UK) in blocking buffer at 4°C. These were then washed extensively in PBS containing 0.05% Tween 20 T-PBS and incubated for one hour with horseradish peroxidase-conjugated anti-mouse IgG (Amersham, Arlington Heights, IL) diluted at 1:1000 in blocking buffer without 0.05% NaN 3 . Antibody binding was visualized using an enhanced chemiluminescence detection kit (Amersham). We used FLAG-tagged genes for FOXO3, PRDM1, ATG5, HACE1, LACE1 and PREP (Supplementary Table 2 ), hence detection was conducted using anti-FLAG antibody. Since the A20 construct was made without a FLAG-tag, anti-A20 antibody was used. Anti-FLAG antibody or anti-A20 antibody was initially incubated to detect the target gene product. Membranes were subsequently stripped using 0.1M Glycine -HCL buffer (pH 2.5) and then incubated with anti-actin antibody.
Apoptosis and cell cycle assay
Apoptotic cell death was determined using the Annexin V APC Apoptosis Detection Kit (eBioscience) according to the manufacturer's instructions. Briefly, cells were washed in serum(-) medium and stained for 15 minutes at room temperature. For the cell cycle assay, propidium iodide For personal use only. on April 13, 2017. by guest www.bloodjournal.org From (PI) staining was performed according to the method described in a previous report with some modifications 30 . Briefly, 5x10 5 cells were incubated in 1 ml PBS containing 0.1% Triton X-100 (Sigma Aldrich), 0.5% RNase A (Qiagen) and 20 mg/ml PI (Wako, Osaka, Japan). Analyses were performed using a FACS Caliber (BD Biosciences) instrument and FlowJo software (Tommy Digital Biology, Tokyo, Japan).
Microarray data accession number.
The microarray data obtained in this study have been submitted to ArrayExpress and assigned accession numbers E-MEXP-3002 (array CGH) and E-MEXP-2996 (gene expression).
Results
Gene expression profile of NK cell neoplasm
Comprehensive gene expression profiles of seven NK cell lines and eleven clinical samples were analyzed (Table1 and Supplementary Table 1 ). The gene expression profiles of NK cells from normal donors were analyzed as control samples. Genes associated with the cell cycle, DNA replication, and angiogenesis were more highly expressed in neoplastic samples compared with normal NK cells (Supplementary Table 3 , 5 and 7). We then compared the expression profiles of clinical samples and cell lines. Several pathways associated with inflammation, e.g. the CCR5 pathway (Fos, Jun, CCL4 etc), and those associated with immunosuppression, e.g. the PD1 signal (CD4, PDCD1, CD274 etc), were highly expressed in clinical samples (Supplementary Tables 4, 6 and 7).
Genomic profile of NK cell neoplasm
Oligo-array CGH was performed on thirty-two clinical samples and seven cell lines ( Figure 1(a) ). Furthermore, oligo-array CGH could detect the narrow genomic aberrations which previous BAC-array CGH failed to detect (Supplementary Figure 1(b) ).
Figure 1(a) shows the results of oligo-array CGH for the thirty-nine samples analyzed. The gains of 1q31. 2-44, 7q11.22-36.3, 16p13.3 and 11p15.5 , and the losses of 6q16.1-27 and 7p15.3-22.2 were found in more than eight cases (20%). 6q21 loss was the most frequent aberration. The narrow deleted region of 6q21 found in HANK1 contained five known genes, POPDC3, PREP, PRDM1, ATG5 and AIM1, and that found in clinical sample no.3 contained two known genes, LACE1 and FOXO3. These regions were considered as the most frequently deleted minimal common region (MCR) (14/39, 36%) (Figure 1(b) ). FISH analysis showed heterozygous deletion of the genomic region covering FOXO3 in NKL, SNK6 and SNK10, while no aberration was found in KHYG1, NK92,
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From HANK1 and NKYS. These results were in accordance with the results of oligo-array CGH (Figure  4(a) ). We then analyzed the expression level of these seven candidate tumor suppressor genes located on the most frequently deleted MCR of NK cell neoplasms. Moreover, TNFAIP3 (A20) and HACE1 were included as candidate genes. The genomic regions including A20 and HACE1 were deleted in 28% and 31% of the analyzed cases, respectively. A20 has been reported as a tumor suppressor gene in B cell lymphoma 31, 32 . HACE1 has been reported as a tumor suppressor gene 7, 33 and as one of the candidate genes associated with ENKTL 7, 33 .
Selection of candidate genes by a combination of genomic and expression profiles
The expression levels of candidate genes (POPDC3, PREP, PRDM1, ATG5, AIM1, LACE1, FOXO3, A20 and HACE1) within cell lines, clinical samples and normal NK cells were analyzed by oligo-microarray. All genes had at least one probe on the microarray chip for the gene expression profile, and a signal was detected for all genes except POPDC3 in normal NK cells. Since the signal intensity of the POPDC3 probe in normal NK cell was very low and regarded as "flagged data", we could not compare the expression level of this gene and excluded it from analysis. Figure  1 (c) shows the expression levels in neoplastic samples compared with those in normal NK cells. A20 and FOXO3 were the top two down-regulated genes in neoplastic samples, while AIM1 expression did not differ between normal NK cells and neoplastic samples.
Selection of candidate genes by functional analysis
POPDC3 and AIM1 were excluded from the candidate gene list since the former was not expressed in normal NK cells, and expression of the latter was similar in normal NK cells and neoplastic samples. The remaining seven genes were transduced into the NK cell line in an effort to investigate the functional effects.
We chose NKL, SNK6 and SNK10 for gene transduction since these lines possess the 6q deletion. Gene transduction was initially attempted using lentivirus
31
. However, functional effect analysis was difficult using this method since the transduction efficiency was less than 10% for each cell line utilized (data not shown). The generation of a Tet-Off cell line using drug selection was then attempted (Figure 2(a) ). Although Tet-Off NKL and SNK10 lines were successfully established, the Tet-Off SNK6 line could not be established due to low transduction efficiency and difficulties associated with single-cell cloning. pRetroX-Tight-Pur-EGFP was transduced into Tet-Off NK cell lines to investigate the induction efficiency. As shown in Figure 2 (b), high EGFP expression was successfully induced in more than 95% of total cells. Figures 2(e), (f) and (g) show that each candidate gene was transduced and induced in Tet-Off NK cell lines. Tet-OFF NKL with doxycyclin-induced suppression of FOXO3 or PRDM1 expression proliferated logarithmically, whereas proliferation was suppressed with the induction of these gene expression (Figure2 (e), upper panel). On the other hand, the induction of ATG5, A20, HACE1, PREP or LACE1 had no effect on cell proliferation, despite the large amount of protein expressed (Figure2(e),(f) ). The suppression effect by re-expression of PRDM1 and FOXO3 was confirmed using Tet-Off SNK10
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From (Figure 2(g) ). Although PRDM1 induction also suppressed Tet-Off NKL proliferation, the suppression efficiency was weaker compared with FOXO3 (Figure2 (e) and (f)). We then examined time-course changes in the expression of FOXO3 and PRDM1 at days 0, 1, 2 and 5 following removal of doxycyclin. The expression of both genes decreased at day 2 after the initial increase at day 1, and the PRDM1 expression level was lower than that of FOXO3 (Figure 2(d) ). From these findings, FOXO3 and PRDM1 were highly suspected to play more important roles as tumor suppressor genes than the other candidate genes located on 6q21-23. Therefore, the status of FOXO3 and PRDM1 in NK cell neoplasms was further analyzed in detail.
Apoptosis and cell cycle arrest induced by re-expression of FOXO3 and PRDM1
Apoptosis and cell cycle assays were performed in an effort to examine the effect of FOXO3 and PRDM1 re-expression (Figures 3(a) and (b)). Apoptosis assays using Annexin V revealed that FOXO3 re-expression increased the amount of apoptotic cells five days following removal of Doxycyclin (Figure 3(a) ). No clear changes were observed in cells re-expressing PRDM1 at either day two or five following removal of Doxycyclin (Figure 3(a) ). Cell cycle assays using PI revealed that the proportion of cells in the S-phase decreased in both FOXO3-and PRDM1-induced cells (Figure 3(b) ). Interestingly, the suppression of S-phase cells was more obvious at day two than at day five in the FOXO3-induced cell line, while the suppression of S-phase cells was more obvious at day five than at day two in the PRDM1-induced cell line.
Down-regulated expression and genomic mutation of PRDM1 and FOXO3 genes in NK cell neoplasms
Semi-quantitative RT-PCR of PRDM1 and FOXO3 was performed for seven cell lines and seven clinical samples to validate the gene expression profile of oligo-microarray. Thirteen out of fourteen samples (FOXO3) and ten out of fourteen samples (PRDM1) showed lower expression levels compared with normal NK cells (Figure 4(b) ). The average expression levels of both genes in neoplastic samples were significantly lower than those in normal NK cells, reflecting the result of oligo-microarray. Although neoplastic samples with the 6q deletion tended to express both genes at a lower level than samples without the 6q deletion, some cases without 6q deletion showed extremely low expression levels. Therefore, no significant difference was observed in the expression levels between neoplastic cases with the 6q deletion and those without the 6q deletion (P-value: FOXO3:0.44, PRDM1:0.07).
Mutation analyses of FOXO3 and PRDM1 were then performed to detect the genomic aberrations. Genomic sequences of protein coding regions and splice junctions were analyzed among the seven cell lines and available thirty-three clinical samples. The insertion and/or deletion of For personal use only. on April 13, 2017. by guest www.bloodjournal.org From nucleotides was absent for both genes. One-nucleotide substitutions registered as SNPs in the NCBI database (http://www.ncbi.nlm.nih.gov/gene/) were found in twenty-seven cases (PRDM1) and four cases (FOXO3) (data not shown). A synonymous one-nucleotide substitution not registered in the database was found in FOXO3 of HANK1. As shown in Figure 4 (c), a nonsense mutation of PRDM1 was found in one cell line (NK92) and one clinical sample (no.24). Re-expression of truncated PRDM1 mutants derived from case no. 24 (PRDM1
174STOP
) and NK92 ( PRDM1 203STOP ) failed to show growth suppression, indicating that this is actually a loss-of-function mutation (Figure 2(f) ). Non-synonymous amino-acid changes of FOXO3 were found in 3 clinical samples (nos. 8, 11 and 21) and these nucleotide substitutions were suspected as somatic missense mutations since the nucleotide substitutions were not registered in the SNP database. FOXO3 mutants from case nos. 8 and 11 were successfully amplified by PCR methods. Re-expression of FOXO3 mutants suppressed cell growth as well as wild-type FOXO3 (2(f)). No mutations were detected in the splice junctions. Case no. 11 with a FOXO3 mutation and no. 24 with a PRDM1 mutation possessed the 6q deletion, while other samples were free from the 6q deletion.
Discussion
The precise mechanisms associated with the molecular pathogenesis of NK cell neoplasms remain to be delineated. This study combined gene expression analysis and genomic profiles to generate a list of candidate genes involved in NK cell neoplasms. In an attempt to examine functional relevance, we established NK cell lines susceptible to induced gene expression. This approach employing a combination of different assays focused on fewer candidate genes more likely to be associated with the pathogenesis of NK cell neoplasms.
The results of the gene expression profiles reflected the neoplastic characters well. Genes associated with cell proliferation and the cell cycle were up-regulated in neoplastic samples compared with normal NK cells. On the other hand, the expression levels of genes and gene sets associated with tumor microenvironments differed between clinical samples and cell lines. Huang et al 34 analyzed gene expression profiles of ENKTL and reported that gene sets associated with signal transduction, e.g. the JAK/STAT and MAP kinase pathways, were up-regulated in neoplastic samples. The expression levels of these signal transduction-associated gene sets did not differ between neoplastic samples and normal NK cells in this study. This may be due to our analyses being based on the MSigDB database (http://www.broadinstitute.org/gsea/msigdb/index.jsp) or Gene ontology (http://bioinfo.vanderbilt.edu/webgestalt/analysis.php?gofile_organism=hsapiens). For example, the gene set of the JAK/STAT pathway in MSigDB (referred to as KEGG_JAK_STAT_SIGNALING_PATHWAY) contains no less than 155 genes, including genes up-regulated by JAK-STAT pathway activation in addition to those being down-regulated. If we had selected the same genes associated with the JAK/STAT pathway as used by Huang et al, this gene set would have been expressed higher in neoplastic samples compared with normal NK cells (NES:-1.44, nom-p-value:0.095, data not shown).
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We previously reported BAC-array CGH analysis of NK cell neoplasms. In this study, we performed oligo-array CGH analysis in an effort to identify more detailed and narrower genomic aberrations. Gain of 1q and 7q and loss of 6q and 7p were relatively frequent genomic aberrations. These abnormalities were consistent with previous reports. 4, [7] [8] [9] 34 . In particular, narrow regions of 6q21 that includes POPDC3, PREP, PRDM1, ATG5, AIM1, LACE1 and FOXO3 were the most frequently deleted region of the whole genome except for the X and Y chromosomes. Iqbal et al 8 also
performed array CGH analysis of NK cell neoplasm and described PRDM1, ATG5 and AIM1 as strong candidate genes. We included TNFAIP3 (A20) and HACE1 in the candidate gene list since they have been described as tumor suppressor genes in many previous reports [31] [32] [33] 35, 36 . Although these were not located on the most frequently deleted MCR, 29% and 31% of cases showed deletion of these genes. The expression levels of POPDC3 and AIM1 did not differ between neoplastic samples and normal NK cells. Huang et al 7 reported that AIM1 expression was down-regulated in ENKTL, although this down-regulated expression was not detected in other studies 8 performed by Iqbal et al and by our group. In this study, POPDC3 and AIM1 were excluded from our functional analysis. Further studies will be needed to confirm the expression level and detailed mechanism of AIM1. Forced re-expression of the other seven genes was successfully achieved, and only FOXO3 and PRDM1 induction resulted in the suppression of cell proliferation.
A20 functions to suppress NF-κB signaling by targeting RIP1 and TRAF6 37, 38 . Frequent genomic aberrations of A20, comprising homogeneous deletions and biallelic inactivation with genomic mutation, have been described in B cell lymphoma including diffuse large B cell lymphoma and MALT lymphoma 31, 32, 35, 39 . Kato et al 32 and our group 31 confirmed that A20 re-expression in the B cell lymphoma cell line and Hodgkin lymphoma cell line suppressed cell proliferation. However, this effect was not observed in the NK cell line although NKL possessed a 6q deletion encompassing the A20 gene. In contrast to B cell lymphoma, A20 was not located in the most frequently deleted MCR in NK cell neoplasms and homogeneous deletion was not observed. This result indicates that A20 may not play an important role in the pathogenesis of NK cell neoplasms as it does in B cell neoplasms. However, previous reports have indicated NF-κB activation in NK cell neoplasms as well as B cell neoplasms 7, 34, 40, 41 . The EB-virus, frequently detected in NK cell neoplasms, was reported to induce NF-κB activation through LMP1 42 . The action of the EB-virus may replace A20 inactivation in the NF-κB activation of NK cell neoplasms.
HACE1 is a gene encoding E3 ubiquitin ligase and was reported to be inactivated by DNA methylation in gastrointestinal tract cancer and Wilms` tumor 33, 36, 43 . Spontaneous multi-organ tumors frequently occur in HACE1 -/-mice 33 . From these findings, HACE1 is regarded as one of the tumor-suppressor genes in certain kinds of cancers as well as in NK cell neoplasms 7, 33, 34, 36, 44 .
Huang et al 7 described HACE1 as a candidate genes since it was not only located within the frequently deleted region, but its expression was down-regulated in tumor samples. In this study, HACE1 expression in neoplastic samples was also down-regulated compared with normal NK cells (data not shown). However, an obvious tumor suppressing effect was not observed in our functional analysis.
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From FOXO3 is a member of the fork head family of proteins which possess the fork-head box domain, a DNA binding domain that is highly conserved among various biological species 45 . In hematological malignancies, translocation involving the FOXO3 and MLL genes was detected in acute leukemia, indicating an association with pathogenesis 48 . From these findings, FOXO3 is now recognized as a tumor suppressor gene. However, there have been no reports describing the role of FOXO3 in malignant lymphoma, especially in the case of NK cell neoplasms. In this study, FOXO3 expression was down-regulated in most NK cell neoplasms and re-expression of FOXO3 suppressed proliferation of the NK cell line. These findings indicate that FOXO3 plays a role as a tumor suppressor gene in NK cell neoplasms. It was shown that the inhibition of cell growth by FOXO3 re-expression was due to the induction of apoptosis and cell cycle arrest (Figures 3(a) and (b)). These findings are consistent with previous reports 46, 47 .All cell lines possessing 6q deletions showed heterozygous loss and mRNA expression was detected even though the expression was down-regulated. Furthermore, only one case showed a genomic mutation of FOXO3 with accompanied genomic loss. These findings tend to favor haploinsufficiency in lieu of biallelic inactivation as being the mechanism responsible for FOXO3 inactivation in NK cell neoplasms.
PRDM1/BLIMP1 is a transcriptional repressor comprising Kruppel-type zinc fingers which combine DNA with the PR domain, and is a master regulator of B cell differentiation 49 . This gene product is considered as a tumor suppressor gene since about 25% of activated B-cell type diffuse large B cell lymphoma cases showed genomic mutations which induce functional inactivation 28, 50 . Most of these cases with inactive mutations were accompanied by heterogeneous 6q deletions and DNA methylation, indicating that biallelic inactivation occurs frequently 28, 50 . Iqbal et al 8 reported that PRDM1 expression was down-regulated in NK cell neoplasms, while Huang et al 7 reported no difference in expression levels between ENKTL and normal NK cells. In this study, PRDM1 expression was down-regulated in NK cell neoplasms compared with normal NK cells. However, the expression levels varied, as some neoplastic cases showed extremely up-regulated expression compared with normal NK cells (Figure 4(b) ). This variation in expression level may account for previous reports which showed the opposite effect. In this study, the inhibition of cell growth by PRDM1 re-expression was less effective compared with FOXO3 re-expression (Figure 2(e) ). The expression level of PRDM1 was less than that of FOXO3, even though the same tet-off system vector was used for the expression of both genes (Figure 2(d) ). Differences in the expression level of each gene may have contributed to differences in the suppression effect observed. Genomic mutations in two cases represented nonsense mutations, resulting in inactive mutations ( Figure  4 (c)). One case was accompanied by a genomic deletion, and biallelic inactivation was considered in this case. Although this indicates that PRDM1 may play a role as a classical tumor suppressor gene based on the two-hit theory, future studies employing more cases are required to clarify this possibility 51 .
In this study, we succeeded in identifying a small group of genes as candidate tumor suppressor genes by combining array CGH, gene expression profile and functional analyses. The transduction
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From of NK cell lines is generally difficult, even when using viral infection methods. This is the first study to establish a stable inducible gene expression system in the NK cell line, and the assay system developed should prove useful in delineating the molecular pathogenesis of NK cell neoplasms. Interestingly, the well known onco-suppressor genes A20 and HACE1 had no effect on NK cell line proliferation, while the suppression of proliferation was clearly demonstrated with PRDM 1and FOXO3 re-expression. The down-regulation of these two genes is considered to play an important role in the pathogenesis of NK cell neoplasms. 
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Figure2: Re-expression of candidate genes into 6q-deleted NK cell lines (a) Schema outlining gene transduction and induction using the Tet-Off system. The Retro-X Tet-Off Advanced inducible expression system (Clontech) was used. tTA was initially transduced by retro-viral infection, and was followed by neomycin (G418) selection. Selected cells were cloned by limiting dilution, and a clone with the highest induction efficiency was isolated. cDNA of the gene of interest (GOI) was then inserted into pRetroX-Tight-Pur and transduced into the isolated clone. Following puromycin selection, doxycyclin was removed and cells were observed for six days. The Western blot shown is representative of the result obtained following incubation of anti-FLAG antibody with the cellular extract from the FLAG-PRDM1 transduced cell line. tTA, Tet-controlled transactivator; TRE, tetracyclin response element; GOI, gene of interest; Neo, neomycin selection; Pur, puromycin selection.
(b) Induction efficiency of the Tet-OFF system was analyzed using pRetroX-Tight-Pur-GFP. pRetroX-Tight-Pur-GFP was transduced and selected as described in (a). Over 95% of the cells showed induced GFP expression.
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From (c) Western blot analysis. Gene expression was induced as described in (a). 1x10 6 cells were resuspended in 100ul of 2x sample buffer (125 mM Tris, pH6.8, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol and 0.02% bromophenol blue) and 10ul was subjected to polyacrylamide gel electrophoresis. Following transfer of the separated proteins onto the membrane, the membrane was incubated with anti-FLAG antibody for FOXO3, PRDM1, ATG5, HACE1, LACE1 and PREP, and with anti-A20 antibody for A20 (upper panel). Anti-actin antibody was then incubated with the membrane after stripping to measure cellular extract quantity (lower panel). The molecular size marker, 97kd, is indicated by an arrowhead.
(d) Time-course changes with FOXO3 and PRDM1 re-expression. Cell samples at days 0, 1, 2 and 5 were analyzed as described in Figure 2 (c). Each band was converted to a numerical value using Image-J and the ratio to actin was calculated and is shown below each band.
(e) Effect of re-expressed PRDM1 or FOXO3 on NKL. 1x10 5 cells were re-suspended in medium with or without doxycyclin (Day 0). On day2, cells were diluted by up to 10-fold and new medium was added since the cells had reached confluence. The horizontal axis indicates time elapsed following doxycyclin removal. The vertical axis indicates the average and standard deviation of the cell number ratio (Dox-/Dox+). Cell numbers were determined using the trypan blue dye exclusion assay. Experiments were performed in triplicate. Cell proliferation was strictly suppressed on Day 6 when FOXO3 and PRDM1 were re-expressed, unlike the case with A20.
(f) Each candidate gene, PRDM1 mutant (PRDM1 174STOP and PRDM1
203STOP
) and FOXO3 mutant (FOXO3 P8R and FOXO3 I646F ), was induced as described in (d). Medium change and dilution was performed on Day2 and cell counts were determined on Day 6. The vertical axis indicates the ratio of cell number with and without doxycyclin. Experiments were performed in triplicate and standard deviations and average scores are described. Candidate genes, except in the case of FOXO3 and PRDM1, had no effect on cell proliferation, although these genes were induced and protein expression was confirmed. *significantly lower than vector control (p<0.05).
(g) Effect of re-expressed PRDM1 or FOXO3 on SNK10. 1x10 5 cells were re-suspended in medium with or without doxycyclin (Day 0) and analyzed as described in (d). On Day 2, cells were diluted 5-fold. Cell proliferation was suppressed on Day 6 when FOXO3 and PRDM1 were re-expressed, while the control genes (vector control and GFP) had no effect. *significantly lower than vector control (p<0.05). For personal use only. on April 13, 2017. by guest www.bloodjournal.org From Experiments were performed in triplicate and standard deviations and average scores are shown. Dox; doxycyclin, *significantly different Dox(-) and Dox(+) samples (p<0.05).
(b) Cell cycle assay. Cell cycle assays were conducted using propidium iodide (PI) at days 2 and 5. The upper panel shows a representative result of FOXO3 re-expressing cells at day 2. The proportion of S-phase cells was lower under conditions without doxycyclin treatment than those with doxycyclin treatment. The lower panel shows the proportion of S-phase cells at days 2 and 5. FOXO3 re-expression decreased the proportion of S-phase cells at days 2 and 5, while a decrease in the proportion of S-phase cells only occurred at day 5 with PRDM1 re-expression. Experiments were performed in triplicate and standard deviations and average scores are shown. *significantly different Dox(-) and Dox(+) samples (p<0.05). 25, 27, 28, 30, 26, 31 and 32) . Normal NK cells from one representative donor were also analyzed. Each band was converted to a numerical value using Image-J and the ratio to beta-actin was calculated. The ratio of normal NK cells and each neoplastic sample is shown below each band. *samples with a 6q21 deletion, **HANK1 accompanied the deletion of PRDM1, but not FOXO3.
(c) Mutation analysis of FOXO3 and PRDM1. The schema outlines the functional domain and location of the mutation. The mutation is shown as triangle on the map. The electrofluorogram shows that the mutation is located on exon 5 in NK92, and is aligned with the case without mutation. Missense mutations of FOXO3 were found in three cases and nonsense mutations of PRDM1 were found in two cases. 
